全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 102029-81-2 | Alanine-1-13C;Alanine-1-13C;Ccris 6559;282421_Aldrich | C3H7NO2 |
| 102029-87-8 | Adenosine 5'-(trihydrogen diphosphate) cyclohexanamine salt | C10H15N5O10P2.2(C6H13N) |
| 102029-89-0 | H-Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH;Sar-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-OH;H-Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH;[Sar1]Angiotensin II【Guinea Pig】 | C49H71N13O10 |
| 102029-92-5 | L-Arginyl-L-phenylalanine diacetate | C15H23N5O3.2(C2H4O2) |
| 102029-95-8 | 5'-Adenylic Acid Monoanhydride With Sulfuric Acid Disodium Salt;ADENOSINE-5'-O-PHOSPHOSULFATE SODIUM SALT;ADENOSINE 5'-PHOSPHOSULFATE SODIUM SALT;ADENOSINE 5'-PHOSPHOSULFATE SODIUM | C10H13N5NaO10PS |
| 102029-99-2 | N-(Phenylmethyl)-L-histidine methyl ester dihydrochloride | C14H17N3O2.2(HCl) |
| 102036-29-3 | Protosappanin B;(-)-Protosappanin B; (7S,12aS)-7,8-Dihydro-7-(hydroxymethyl)-6H-dibenz[b,d]oxocin-3,7,10,11-tetrol | C16H16O6 |
| 102040-03-9 | Tubeimoside A | C63H98O29 |
| 102042-09-1 | 21-Hydroxyoligomycin A;(4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22S,28S)-22-Ethyl-7,11,14,15,23-Pentahydroxy-6'-[(2R)-2-Hydroxypropyl]-5',6,8,10,12,14,15,16,28-Nonamethyl-Spiro[2,26-Dioxabicyclo[23.3.1]Nonacosa-4,18,20-Triene-27,2'-Tetrahydropyran]-3,9,13-Trione;(4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22S,28S)-22-Ethyl-7,11,14,15,23-Pentahydroxy-6'-[(2R)-2-Hydroxypropyl]-5',6,8,10,12,14,15,16,28-Nonamethylspiro[2,26-Dioxabicyclo[23.3.1]Nonacosa-4,18,20-Triene-27,2'-Tetrahydropyran]-3,9,13-Trione;(4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22S,28S)-22-Ethyl-7,11,14,15,23-Pentahydroxy-6'-[(2R)-2-Hydroxypropyl]-5',6,8,10,12,14,15,16,28-Nonamethyl-Spiro[2,26-Dioxabicyclo[23.3.1]Nonacosa-4,18,20-Triene-27,2'-Oxane]-3,9,13-Trione | C45H74O12 |
| 102044-69-9 | Ceftizoxime Impurity 30 (Double Bond 2-Isomer);(2R,6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid | C13H13N5O5S2 |
| 102045-96-5 | (S)-2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid;(S)-2,2-Dimethyldioxolane-4-carboxylic acid; (S)-2,3-(Isopropylidenedioxy)propionic acid | C6H10O4 |
| 102047-33-6 | N-[(Benzyloxy)Carbonyl]-L-Alanyl-6-Imino-L-Lysyl-6-Imino-N-(4-Methoxy-2-Naphthyl)-L-Lysinamide Acetate (1:1);Acide acé<wbr>tique - N<wbr>-[(benzyl<wbr>oxy)carbo<wbr>nyl]-L-al<wbr>anyl-6-im<wbr>ino-L-lys<wbr>yl-6-imin<wbr>o-N-(4-mé<wbr>thoxy-2-n<wbr>aphtyl)-L<wbr>-lysinami<wbr>de (1:1);L-Lysinam<wbr>ide, N-[(<wbr>phenylmet<wbr>hoxy)carb<wbr>onyl]-L-a<wbr>lanyl-6-i<wbr>mino-L-ly<wbr>syl-6-imi<wbr>no-N-(4-m<wbr>ethoxy-2-<wbr>naphthale<wbr>nyl)-, ac<wbr>etate (1:<wbr>1);N-[(Benzy<wbr>loxy)carb<wbr>onyl]-L-a<wbr>lanyl-6-i<wbr>mino-L-ly<wbr>syl-6-imi<wbr>no-N-(4-m<wbr>ethoxy-2-<wbr>naphthyl)<wbr>-L-lysina<wbr>midacetat<wbr> (1:1) | C36H48N8O8 |
| 102052-95-9 | 3-Deazaneplanocin;(1S,2R,5R)-5-(4-Amino-1H-imidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)-3-cyclopentene-1,2-diol; NSC 617989 | C12H14N4O3 |
| 102056-97-3 | N-Tritylhomoserine - N,N-Diethylethanamine (1:1);N-TRITYL-L-HOMOSERINETRIETHYLAMINESALT | C29H38N2O3 |
| 102062-46-4 | 3-[(4'-Amino-3,3',5,5'-tetramethyl[1,1'-biphenyl]-4-yl)amino]-1-propanesulfonic acid monosodium salt | C19H25N2O3SNa |
| 102065-86-1 | Azetidin-3-amine dihydrochloride | C3H8N2.2(HCl) |
| 102065-89-4 | 3-Azetidinamine dihydrochloride | C3H8N2.2(HCl) |
| 102065-92-9 | 3-Acetamidoazetidine hydrochloride | C5H10N2O.HCl |
| 102068-15-5 | PGLa;741: PN: US20050058603 SEQID: 736 claimed protein; MSI 499; PGLa; PGLa ion channel-forming peptide | C88H162N26O22S |
| 102072-84-4 | 5-Phthalazinamine;MFCD08272072;phthalazine-5-ylamine;Quinazolin-8-amine | C8H7N3 |
| 102074-19-1 | 5-Methyl-3-pyridinemethanol;3-Hydroxymethyl-5-methylpyridine; (5-Methylpyridin-3-yl)methanol | C7H9NO |
| 102082-89-3 | 2,6-Difluorocinnamic acid;trans-2,6-Difluorocinnamicacid; (2E)-3-(2,6-Difluorophenyl)acrylic acid | C9H6F2O2 |
| 102088-01-7 | 1,2,3-(1,3-<Sup>13</Sup>C<Sub>2</Sub>)Propanetriol;[1,3-13C2]glycerol;Glycerol-1,3-13C2;492639_ALDRICH | C13C2H8O3 |
| 102088-39-1 | 37,38,39,40,41,42-Hexahydroxy-Heptacyclo[31.3.1.13,7.19,13.115,19.121,25.127,31]Dotetraconta-1(37),3,5,7(42),9,11,13(41),15,17,19(40),21,23,25(39),27,29,31(38),33,35-Octadecaene-5,11,17,23,29,35-Hexasulfonic Acid;Hexahydroxycalix[6]Arenehexasulfonic Acid Hexasulfo(Hexahydroxy)Calix[6]Arene;4-SULFOCALIX[6]ARENE (CONTAINS CA.15% WATER);HEXAHYDROXYCALIX[6]ARENEHEXASULFONIC ACID | C42H36O24S6 |
| 102089-74-7 | Boc-D-Phenylglycinol;(R)-N-(tert-Butoxycarbonyl)-2-phenylglycinol | C13H19NO3 |
| 102092-51-3 | (3-Bromophenyl)(4-Methylphenyl)Methanone;(3-Bromophenyl)(p-tolyl)methanone;3-Bromo-4'-methylbenzophenone;MFCD06201458 | C14H11BrO |
| 102096-60-6 | (3R)-4,4-Dimethyl-2-Oxotetrahydro-3-Furanyl Acetate;O-Acetylpantolactone | C8H12O4 |
| 102096-80-0 | Hydrazine-d<sub>4</sub> mono(hydrate-d<sub>2</sub>) | N2D4.D2O |
| 102110-73-6 | Albumins, Blood Serum, Azo | |
| 102113-98-4 | Bis(4-biphenylyl)amine | C24H19N |
| 102120-96-7 | N-(1,2,3,4-Tetrahydro-5-Methoxy-2-Naphthalenyl)-2-Thiopheneethanamine Hydrochloride (1:1);Rac-N-(1,2,3,4-Tetrahydro-5-Methoxy-2-Naphthalenyl)-2-Thiopheneethanamine Hydrochloride;2-Thiopheneethanamine, N-(1,2,3,4-Tetrahydro-5-Methoxy-2-Naphthalenyl)-, Hydrochloride | C17H22ClNOS |
| 102121-60-8 | 4-[[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbonyl]amino]benzoic acid;Am 580; CD 336; NSC 608001; Ro 40-6055 | C22H25NO3 |
| 102123-28-4 | 3-Amino-4-Cyano-2-Thiophenecarboxylic Acid Methyl Ester;3-Amino-4-Cyanothiophenecarboxylic Acid Methyl Ester;METHYL 3-AMINO-4-CYANOTHIOPHENE-2-CARBOXYLATE;Methyl 3-Amino-4-Cyanothiophen-2-Carboxylate | C7H6N2O2S |
| 102123-74-0 | (3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-2-butanone | C15H20ClNO3 |
| 102125-62-2 | N-Isopropylpiperidine-4-Carboxamide Hydrochloride;MFCD11615741;N-(propan-2-yl)piperidine-4-carboxamide hydrochloride;N-Isopropyl-4-piperidinecarboxamide hydrochloride | C9H19ClN2O |
| 102127-34-4 | 4-Bromo-3-methoxyphenol;4-Bromo-5-methoxyphenol | C7H7BrO2 |
| 102129-65-7 | Disodium,[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-Yl)-3,4-Dihydroxy-Tetrahydrofuran-2-Yl]Methoxy-Oxido-Phosphoryl] [(3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(Hydroxymethyl)Tetrahydropyran-2-Yl] Phosphate;Adenosine-5′-diphosphoglucose disodium salt;Adenosine-5'-diphosphoglucose disodium salt;ADPG | C16H23N5Na2O15P2 |
| 102130-43-8 | Atractyloside potassium salt;(2beta,15alpha)-15-Hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid dipotassium salt | C30H44O16S2.2K |
| 102130-84-7 | Nemadectin;(6R,23S,25S)-5-O-Demethyl-28-Deoxy-25-((E)-1,3-Dimethyl-1-Butenyl)-6,28-Epoxy-23-Hydroxymilbemycin B;Cl 287,088;F28249alpha | C36H52O8 |
| 102137-46-2 | 4-(2-Pyridinylmethoxy)Aniline;4-(2-pyridylmethoxy)phenylamine;4-(Pyridin-2-ylmethoxy)-phenylamine;MFCD04971040 | C12H12N2O |
| 102145-82-4 | 1,1,1-Trifluoro-4-Methoxy-3-Penten-2-One;(Z)-1,1,1-Trifluoro-4-Methoxy-Pent-3-En-2-One;3-Penten-2-One, 1,1,1-Trifluoro-4-Methoxy- | C6H7F3O2 |
| 102151-33-7 | 3-Chloro-4-methoxybenzonitrile | C8H6ClNO |
| 102153-44-6 | 2-Bromo-3-Iodo-Naphthalene;2-BROMO-3-IODONAPHTHALENE | C10H6BrI |
| 102153-48-0 | 5-Nitro-2-bromonaphthalene;6-Bromo-1-nitronaphthalene | C10H6BrNO2 |
| 102153-63-9 | 6-Chloro-2-naphthylsulfonyl chloride | C10H6Cl2O2S |
| 102153-71-9 | 2-Iodo-3-Nitro-Naphthalene;2-IODO-3-NITRONAPHTHALENE | C10H6INO2 |
| 102153-73-1 | 3-Amino-5-Iodobenzoic Acid;3-Amino-5-iodorobenzoic acid | C7H6INO2 |
| 102169-52-8 | 2-Hydrazinocarbonyl-Benzenesulfonamide;2-Carbazoylbenzenesulfonamide;2-(Aminocarbamoyl)Benzenesulfonamide;Zinc03372954 | C7H9N3O3S |
| 102170-24-1 | 1-Methoxypiperidin-4-one;N-Methoxypiperidin-4-one | C6H11NO2 |
| 102170-51-4 | [3-(Aminocarbonyl)-5-Nitrophenyl]-Boronic Acid;3-(Aminocarbonyl)-5-Nitrobenzeneboronic Acid 98%;3-(AMINOCARBONYL)-5-NITROBENZENEBORONIC ACID;3-AMINOCARBONYL-5-NITROPHENYLBORONIC ACID | C7H7BN2O5 |